http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160034982-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fed1697029811b30610d753fba6c47a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c91321b0cda079361b17505dea9c007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b89f7065c33446f91b997668f1b44d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c52ce92bb1bf838005eb8298c38ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e9bd80a489d255a79bead1bab4daeab
publicationDate 2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20160034982-A
titleOfInvention Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
abstract The present invention relates to a pharmaceutical composition for fixed dose oral use for the treatment of tuberculosis, and a method of preparing the same, wherein the oral pharmaceutical composition comprises a) granules comprising isoniazid and at least one granular excipient, b) Granules comprising at least two granular excipients, and c) at least one extragranular excipient.
priorityDate 2013-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135659016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493146
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453030527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451839851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743192
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080742
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1342384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503663
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23683938
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1342384

Total number of triples: 52.